首页> 外文会议>Reporters, markers, dyes, nanoparticles, and molecular probes for biomedical applications IV >Multi-modal in cellulo evaluation of NPR-C targeted C-ANF-peptide and C-ANF-comb nanoparticles
【24h】

Multi-modal in cellulo evaluation of NPR-C targeted C-ANF-peptide and C-ANF-comb nanoparticles

机译:NPR-C靶向的C-ANF肽和C-ANF-梳状纳米颗粒的纤维素评估中的多模式

获取原文
获取原文并翻译 | 示例

摘要

Natriuretic peptides (NPs) are clinical markers of heart disease that have anti-proliferative and anti-migratory effects on vascular smooth-muscle cells (VSMCs). In atherosclerosis, NPs participate in vascular remodeling, where the expression of NP clearance receptors (NPR-Cs) is upregulated both in the endothelium and in VSMCs[l-3]. In this study, we investigated the enhanced targeting potential of novel multifunctional nanoprobes conjugated with multiple copies of a C-type atrial natriuretic factor (C-ANF) peptide fragment to target NPR-C transfected cells. The cell binding results of the NPR-C targeted nanoprobes were compared with that of the C-ANF peptide fragment alone. The nanoprobe and peptide structures contain the chelator DOTA (l,4,7,10-tetraazacyclododecane-l,4,7,10-tetraacetic acid) for labeling with the PET tracer, ~(64)Cu, for radioactive assays and luminescent Eu (III) for confocal cell imaging. Cell assays performed with the radioactive nanoprobe and peptide demonstrated higher cell binding of the targeted nanoprobe comapred with the peptide alone (8.63±1.67 vs. 1.13±0.06). The targeting specificity of both moieties was tested by using the control cell lines NPR-A and NPR-B, and receptor mediated uptake was demonstrated by reduced uptake in the presence of excess unlabeled respective probes.
机译:利钠肽(NPs)是心脏病的临床标志物,对血管平滑肌细胞(VSMC)具有抗增殖和抗迁移作用。在动脉粥样硬化中,NP参与血管重塑,其中内皮和VSMC中NP清除受体(NPR-Cs)的表达均被上调[1-3]。在这项研究中,我们研究了新型多功能纳米探针与C型心房利钠因子(C-ANF)肽片段的多个副本偶联的靶向作用,将其靶向NPR-C转染的细胞。将NPR-C靶向纳米探针的细胞结合结果与单独的C-ANF肽片段的细胞结合结果进行了比较。纳米探针和肽结构包含螯合剂DOTA(1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸),用于用PET示踪剂〜(64)Cu标记,用于放射性测定和发光Eu (III)用于共聚焦细胞成像。用放射性纳米探针和肽进行的细胞分析表明,与单独肽共映射的靶向纳米探针具有更高的细胞结合率(8.63±1.67对1.13±0.06)。通过使用对照细胞系NPR-A和NPR-B来测试两个部分的靶向特异性,并且在过量的未标记的相应探针存在下,通过减少摄取来证明受体介导的摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号